Strategic partnerships Ampersand Health collaborates with hospitals, researchers, and pharma through real world evidence propositions and studies, signaling potential for co-development deals, data access arrangements, and pilot programs with life sciences organizations.

Dermatology expansion Recent launches of the My Derm and other dermatology focused apps indicate opportunities to offer digital health resources, patient engagement tools, and remote monitoring services to dermatology clinics, clinics networks, and pharma sponsors focused on inflammatory skin conditions.

Longitudinal patient data With a focus on long-term inflammatory and oncologic/immune conditions and real world data analytics, there is potential to commercialize predictive analytics offerings, RWE generation contracts, and payer-ready outcomes studies for HCPs and researchers.

Clinical integration Existing collaborations with NHS trusts and teaching hospitals suggest sales pathways through integrated care systems and digital health platform integrations, including EHR/portal interoperability and health information exchanges.

Funding and growth A revenue range of one to ten million and backing from specialized investors imply readiness for scale-up partnerships, channel sales, and co-invested ventures with venture-backed health tech firms looking to expand into oncology, immunology, and inflammation care.